HIV-Infected Latin American Asylum Seekers in Europe: Insights From the EuroLatin HIV Cohort
NCT05998499 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 631
Last updated 2023-08-21
Summary
This is a longitudinal observational study conducted in Europe that describes migrants infected with HIV from Latin America who come to Europe with the intention of seeking asylum or international protection. The aim of the study is to identify the barriers this population faces in accessing the healthcare system and to assess disease control
Conditions
- HIV-1-infection
- Sexually Transmitted Diseases
Interventions
- OTHER
-
Description
This study aimed to understand the situation of Latin American HIV-positive migrants seeking asylum in Spain and identify the challenges they encounter in getting HIV treatment. The main result measured was the proportion of participants with an HIV-1 RNA level of 50 copies/mL or higher at their first clinic visit
Sponsors & Collaborators
-
Hospital Universitario Infanta Leonor
lead OTHER
Principal Investigators
-
Pablo Ryan Murua, MD, PhD · Hospital Universitario Infanta Leonor
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-01-30
- Primary Completion
- 2023-04-30
- Completion
- 2023-07-15
Countries
- Spain
Study Locations
More Related Trials
-
Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France
NCT06799338 ·Status: RECRUITING
-
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain
NCT00685191 ·Status: COMPLETED ·Phase: PHASE4
-
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
NCT02246998 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701
NCT00435838 ·Status: COMPLETED
-
Switching From PI to RALtegravir in HIV Stable Patients
NCT00528892 ·Status: COMPLETED ·Phase: PHASE3
-
TMC125-TiDP35-C239 - Continued Access to Etravirine (ETR) in Treatment Experienced HIV-1 Infected Participants
NCT00980538 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101
NCT05143307 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
Implementing Long-Acting Novel Antiretrovirals
NCT05294159 ·Status: COMPLETED
-
Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.
NCT00386659 ·Status: TERMINATED ·Phase: PHASE4
-
Cohort IMEA 070 -Lenacapavir Compassional
NCT06289361 ·Status: ACTIVE_NOT_RECRUITING
-
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
NCT03405935 ·Status: COMPLETED ·Phase: PHASE3
-
LoViReT (Low Viral Reservoir Treated Patients)
NCT02972931 ·Status: COMPLETED
-
Open-Label Multi-Centre Randomised Switch Study to Evaluate Virological Efficacy Over 96Weeks Of 2-Drug Therapy With Dolutegravir(DTG)/Rilpivirine(RPV) Fixed Dose Combination(FDC) in Antiretroviral Treatment-Experienced HIV-1 Infected Subjects Virologically Suppressed With NNRTI Mutation K103N
NCT05349838 ·Status: COMPLETED ·Phase: PHASE3
-
Evolution of HIV Reservoir, Inflammation and Microbiota Footprint of PLWH Switching to Long-acting Injectable Treatment Compared to Patients on Oral Dual or Triple Anti-integrase-based Therapy
NCT05303337 ·Status: RECRUITING
-
Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
NCT00554398 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Pilot Study to Evaluate Switching From a Regimen Consisting of Raltegravir Plus Emtricitabine/Tenofovir DF Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients
NCT01533259 ·Status: COMPLETED ·Phase: PHASE3
-
Darunavir/Ritonavir + Lamivudine Versus Darunavir/Ritonavir +Emtricitabine/Tenofovir in Naïve HIV-1 Infected Subjects
NCT02770508 ·Status: COMPLETED ·Phase: PHASE4
-
A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real World/
NCT05421806 ·Status: ACTIVE_NOT_RECRUITING
-
Effect Of An Integrase Inhibitor On The Latency And Reservoir Of HIV-1
NCT00807443 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments
NCT06337032 ·Status: RECRUITING ·Phase: PHASE4
-
A Study to Evaluate Virologic Response in Participants Newly Diagnosed With HIV-1
NCT04147325 ·Status: COMPLETED
-
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
NCT06640192 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Cohort of HIV/HBV-coinfected Patients in Europe
NCT04984772 ·Status: ENROLLING_BY_INVITATION
-
CSP #512 - Options in Management With Anti-Retrovirals
NCT00050089 ·Status: COMPLETED ·Phase: NA
-
Identification of Barriers and Facilitators of Implementation of the Out-of-Hospital Administration of the Long- Acting Combination Cabotegravir+Rilpivirina.
NCT06643897 ·Status: COMPLETED ·Phase: NA